These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 17310350)

  • 1. African American ESRD patients have a high pre-dialysis prevalence of kidney stones compared to NHANES III.
    Stankus N; Hammes M; Gillen D; Worcester E
    Urol Res; 2007 Apr; 35(2):83-7. PubMed ID: 17310350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence against a contribution of conventional urine risk factors to de novo ESRD renal stones.
    Stankus N; Worcester E; Hammes M; Coe FL
    Nephrol Dial Transplant; 2006 Mar; 21(3):701-6. PubMed ID: 16326738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discrepancy in the epidemiology of nondiabetic chronic renal insufficiency and end-stage renal disease in black and white Americans: the third National Health and Nutrition Examination Survey and United States Renal Data System.
    Trivedi HS; Pang MM
    Am J Nephrol; 2003; 23(6):448-57. PubMed ID: 14583664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Racial differences in the progression from chronic renal insufficiency to end-stage renal disease in the United States.
    Hsu CY; Lin F; Vittinghoff E; Shlipak MG
    J Am Soc Nephrol; 2003 Nov; 14(11):2902-7. PubMed ID: 14569100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survival Disparity of African American Versus Non-African American Patients With ESRD Due to SLE.
    Nee R; Martinez-Osorio J; Yuan CM; Little DJ; Watson MA; Agodoa L; Abbott KC
    Am J Kidney Dis; 2015 Oct; 66(4):630-7. PubMed ID: 26002293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of chronic and end stage kidney disease in patients with nephrolithiasis.
    Shoag J; Halpern J; Goldfarb DS; Eisner BH
    J Urol; 2014 Nov; 192(5):1440-5. PubMed ID: 24929140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [REIN Report 2011--summary].
    Couchoud C; Lassalle M; Jacquelinet C
    Nephrol Ther; 2013 Sep; 9 Suppl 1():S3-6. PubMed ID: 24119584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polycystic kidney disease at end-stage renal disease in the United States: patient characteristics and survival.
    Abbott KC; Agodoa LY
    Clin Nephrol; 2002 Mar; 57(3):208-14. PubMed ID: 11924752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variation in initial kidney replacement therapy for end-stage renal disease due to lupus nephritis in the United States.
    Devlin A; Waikar SS; Solomon DH; Lu B; Shaykevich T; Alarcón GS; Winkelmayer WC; Costenbader KH
    Arthritis Care Res (Hoboken); 2011 Dec; 63(12):1642-53. PubMed ID: 22058067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of end stage renal disease in African Americans with lupus nephritis.
    Franco C; Yoo W; Franco D; Xu Z
    Bull NYU Hosp Jt Dis; 2010; 68(4):251-6. PubMed ID: 21162701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ESRD caused by nephrolithiasis: prevalence, mechanisms, and prevention.
    Jungers P; Joly D; Barbey F; Choukroun G; Daudon M
    Am J Kidney Dis; 2004 Nov; 44(5):799-805. PubMed ID: 15492945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis C infection is acquired pre-ESRD.
    Bergman S; Accortt N; Turner A; Glaze J
    Am J Kidney Dis; 2005 Apr; 45(4):684-9. PubMed ID: 15806471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The incidence of end-stage renal disease is increasing faster than the prevalence of chronic renal insufficiency.
    Hsu CY; Vittinghoff E; Lin F; Shlipak MG
    Ann Intern Med; 2004 Jul; 141(2):95-101. PubMed ID: 15262664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of end-stage renal disease following live kidney donation.
    Muzaale AD; Massie AB; Wang MC; Montgomery RA; McBride MA; Wainright JL; Segev DL
    JAMA; 2014 Feb; 311(6):579-86. PubMed ID: 24519297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. End-stage renal disease among HIV-infected adults in North America.
    Abraham AG; Althoff KN; Jing Y; Estrella MM; Kitahata MM; Wester CW; Bosch RJ; Crane H; Eron J; Gill MJ; Horberg MA; Justice AC; Klein M; Mayor AM; Moore RD; Palella FJ; Parikh CR; Silverberg MJ; Golub ET; Jacobson LP; Napravnik S; Lucas GM;
    Clin Infect Dis; 2015 Mar; 60(6):941-9. PubMed ID: 25409471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Traditional cardiovascular disease risk factors in dialysis patients compared with the general population: the CHOICE Study.
    Longenecker JC; Coresh J; Powe NR; Levey AS; Fink NE; Martin A; Klag MJ
    J Am Soc Nephrol; 2002 Jul; 13(7):1918-27. PubMed ID: 12089389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human immunodeficiency virus/acquired immunodeficiency syndrome-associated nephropathy at end-stage renal disease in the United States: patient characteristics and survival in the pre highly active antiretroviral therapy era.
    Abbott KC; Hypolite I; Welch PG; Agodoa LY
    J Nephrol; 2001; 14(5):377-83. PubMed ID: 11730270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors influencing access to cardiovascular procedures in patients with chronic kidney disease: race, sex, and insurance.
    Daumit GL; Powe NR
    Semin Nephrol; 2001 Jul; 21(4):367-76. PubMed ID: 11455525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lung Function and Incident Kidney Disease: The Atherosclerosis Risk in Communities (ARIC) Study.
    Sumida K; Kwak L; Grams ME; Yamagata K; Punjabi NM; Kovesdy CP; Coresh J; Matsushita K
    Am J Kidney Dis; 2017 Nov; 70(5):675-685. PubMed ID: 28754455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationships of race and ethnicity to progression of kidney dysfunction and clinical outcomes in patients with chronic kidney failure.
    Lopes AA
    Adv Ren Replace Ther; 2004 Jan; 11(1):14-23. PubMed ID: 14730535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.